Literature DB >> 25970017

Multivalent Antigens for Promoting B and T Cell Activation.

Nitasha R Bennett1, Daniel B Zwick1, Adam H Courtney1, Laura L Kiessling1.   

Abstract

Efficacious vaccines require antigens that elicit productive immune system activation. Antigens that afford robust antibody production activate both B and T cells. Elucidating the antigen properties that enhance B-T cell communication is difficult with traditional antigens. We therefore used ring-opening metathesis polymerization to access chemically defined, multivalent antigens containing both B and T cell epitopes to explore how antigen structure impacts B cell and T cell activation and communication. The bifunctional antigens were designed so that the backbone substitution level of each antigenic epitope could be quantified using (19)F NMR. The T cell peptide epitope was appended so that it could be liberated in B cells via the action of the endosomal protease cathepsin D, and this design feature was critical for T cell activation. Antigens with high BCR epitope valency induce greater BCR-mediated internalization and T cell activation than did low valency antigens, and these high-valency polymeric antigens were superior to protein antigens. We anticipate that these findings can guide the design of more effective vaccines.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25970017      PMCID: PMC4669068          DOI: 10.1021/acschembio.5b00239

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  55 in total

Review 1.  Control systems and decision making for antibody production.

Authors:  Christopher C Goodnow; Carola G Vinuesa; Katrina L Randall; Fabienne Mackay; Robert Brink
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

2.  B cell ligand discrimination through a spreading and contraction response.

Authors:  S J Fleire; J P Goldman; Y R Carrasco; M Weber; D Bray; F D Batista
Journal:  Science       Date:  2006-05-05       Impact factor: 47.728

3.  Stimulation of protein tyrosine phosphorylation by the B-lymphocyte antigen receptor.

Authors:  M R Gold; D A Law; A L DeFranco
Journal:  Nature       Date:  1990-06-28       Impact factor: 49.962

4.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.

Authors:  S Buus; A Sette; S M Colon; C Miles; H M Grey
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

Review 5.  Immunological mechanisms of vaccination.

Authors:  Bali Pulendran; Rafi Ahmed
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

Review 6.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

7.  Antigen presentation by a B-cell line transfected with cloned immunoglobulin heavy- and light-chain genes specific for a defined hapten.

Authors:  M Watanabe; D R Wegmann; A Ochi; N Hozumi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  Isolation and characterization of antigen-Ia complexes involved in T cell recognition.

Authors:  S Buus; A Sette; S M Colon; D M Jenis; H M Grey
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

9.  Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin.

Authors:  S Diment
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

10.  Protein tyrosine phosphorylation is induced in murine B lymphocytes in response to stimulation with anti-immunoglobulin.

Authors:  M A Campbell; B M Sefton
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

View more
  22 in total

Review 1.  Surface engineering for lymphocyte programming.

Authors:  Elana Ben-Akiva; Randall A Meyer; David R Wilson; Jordan J Green
Journal:  Adv Drug Deliv Rev       Date:  2017-05-10       Impact factor: 15.470

2.  Antigen structure affects cellular routing through DC-SIGN.

Authors:  Cassie M Jarvis; Daniel B Zwick; Joseph C Grim; Mohammad Murshid Alam; Lynne R Prost; Jaye C Gardiner; Soyeong Park; Laraine L Zimdars; Nathan M Sherer; Laura L Kiessling
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-03       Impact factor: 11.205

Review 3.  Nanoparticles for generating antigen-specific T cells for immunotherapy.

Authors:  Savannah E Est-Witte; Natalie K Livingston; Mary O Omotoso; Jordan J Green; Jonathan P Schneck
Journal:  Semin Immunol       Date:  2021-12-23       Impact factor: 11.130

Review 4.  Polymeric micro- and nanoparticles for immune modulation.

Authors:  Elana Ben-Akiva; Savannah Est Witte; Randall A Meyer; Kelly R Rhodes; Jordan J Green
Journal:  Biomater Sci       Date:  2018-12-18       Impact factor: 6.843

5.  Physical tuning of galectin-3 signaling.

Authors:  Shaheen A Farhadi; Renjie Liu; Matthew W Becker; Edward A Phelps; Gregory A Hudalla
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

Review 6.  Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages.

Authors:  Pureum Lee; Chang-Ung Kim; Sang Hawn Seo; Doo-Jin Kim
Journal:  Immune Netw       Date:  2021-02-26       Impact factor: 6.303

7.  Interleukin-13 peptide vaccine induces protective humoral immunity in murine asthma models.

Authors:  Fengbo Wu; Yan Huang; Peng Zhang; Chunting Wang; Yaomei Tian; Lian Lu; Gu He; Li Yang
Journal:  Oncotarget       Date:  2017-08-04

8.  The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA.

Authors:  Vadim Jucaud
Journal:  J Immunol Res       Date:  2017-02-26       Impact factor: 4.818

9.  Stereochemical Control Yields Mucin Mimetic Polymers.

Authors:  Austin G Kruger; Spencer D Brucks; Tao Yan; Gerardo Cárcarmo-Oyarce; Yuan Wei; Deborah H Wen; Dayanne R Carvalho; Michael J A Hore; Katharina Ribbeck; Richard R Schrock; Laura L Kiessling
Journal:  ACS Cent Sci       Date:  2021-03-30       Impact factor: 14.553

10.  Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses.

Authors:  Mohammad Murshid Alam; Cassie M Jarvis; Robert Hincapie; Craig S McKay; Jiri Schimer; Carlos A Sanhueza; Ke Xu; Roger C Diehl; M G Finn; Laura L Kiessling
Journal:  ACS Nano       Date:  2020-08-17       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.